EpiPen4Schools pilot survey: Occurrence of anaphylaxis, triggers, and epinephrine administration in a U.S. school setting

Mv, White; Sl, Hogue; Me, Bennett; Goss, Diana; Millar, K.; Hollis, Kelly; Siegel, Peter; Ra, Wolf; Wooddell, MJ; Silvia, Suyapa

doi:10.2500/aap.2015.36.3859

Cited by 48 publications

(60 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…15 The EpiPen4Schools pilot survey involving 6019 schools in the United States also revealed that an AAI was used in 74.7% of 851 anaphylaxis episodes that occurred in 607 schools over one school year from 2013 to 2014. 16 This study did not have details on the total number of students and it is difficult to compare the AAI usage rate, except to note that it is possible that in the school environment, anaphylaxis might be better recognized and an AAI used more appropriately than in the community (as compared with the UK study). However, none of these surveys has details on the number of students already at risk of anaphylaxis.…”

Section: Discussionmentioning

confidence: 96%

Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia

Loke

Koplin

Beck

et al. 2016

Journal of Allergy and Clinical Immunology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 96%

Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia

Loke

Koplin

Beck

et al. 2016

Journal of Allergy and Clinical Immunology

View full text Add to dashboard Cite

show abstract

“…Many immunologic triggers can induce an anaphylactic reaction, the most common being food, insect venom, and medication 5,20–22. The rate of anaphylaxis appears to be increasing dramatically in the developed countries,23,24 which may partially be due to an increase in the prevalence of food allergies 25.…”

Section: Overview Of Anaphylaxismentioning

confidence: 99%

“…The rate of anaphylaxis appears to be increasing dramatically in the developed countries,23,24 which may partially be due to an increase in the prevalence of food allergies 25. Individuals with a previous history of allergic reactions and asthma are at the greatest risk 7,22. However, anaphylaxis can commonly occur in those with no known history of allergy,22 and triggers are never identified in many cases 20–22.…”

Section: Overview Of Anaphylaxismentioning

confidence: 99%

“…Individuals with a previous history of allergic reactions and asthma are at the greatest risk 7,22. However, anaphylaxis can commonly occur in those with no known history of allergy,22 and triggers are never identified in many cases 20–22. Results from one study on a private allergy practice suggest that more than half of all the cases are idiopathic 26.…”

Section: Overview Of Anaphylaxismentioning

confidence: 99%

See 1 more Smart Citation

Update on the usage and safety of epinephrine auto-injectors, 2017

Posner

Camargo

2017

DHPS

View full text Add to dashboard Cite

Anaphylaxis is a serious, potentially fatal allergic reaction. Guidelines recommend prompt intramuscular injections of epinephrine as the first-line therapy for anaphylaxis. Delayed epinephrine treatment may cause undesirable clinical outcomes, including death. In the community, epinephrine auto-injectors (EAIs) are commonly used to treat anaphylaxis. This literature review examines several recent concerns regarding the safety of EAIs that may prevent the timely administration of epinephrine. Reports of cardiovascular complications are linked with epinephrine administration, although recent studies suggest that these events are much more commonly associated with intravenous epinephrine rather than with EAIs. Recent studies have also highlighted accidental injections of EAIs in patients’ or caregivers’ fingers and lacerations associated with the use of EAI in children. However, the data suggest that both accidental injections and lacerations are rare and require limited medical intervention. In addition, patients may receive conflicting information on the safety and efficacy of using expired EAIs. Overall, it is believed that the benefits of using EAIs far outweigh the potential risks of not administering an EAI. Although legitimate safety concerns are associated with EAIs, adverse events are rare. Continued training of medical providers, caregivers, and patients may be beneficial to address these concerns and reduce EAI-associated injuries while ensuring that patients receive necessary medical care.

show abstract

“…21 White et al performed a cross-sectional, web-based survey of 6,019 schools participating in the EpiPen4Schools program which assessed anaphylactic events and epinephrine autoinjector (EAI) use during the 2013-2014 school year. 22 They found that greater than one in ten schools participating in the EpiPen4Schools survey reported an anaphylactic event. Of concern, ϳ25% of anaphylactic events were not treated with EAIs, and 20.4% of patients were not taken to the hospital after an anaphylactic event.…”

mentioning

confidence: 99%